Compounds > l 158809
Page last updated: 2024-09-03

l 158809 and angiotensin ii, des-phe(8)-

l 158809 has been researched along with angiotensin ii, des-phe(8)- in 3 studies

Compound Research Comparison

Studies
(l 158809)		Trials
(l 158809)		Recent Studies (post-2010)
(l 158809)		Studies
(angiotensin ii, des-phe(8)-)		Trials
(angiotensin ii, des-phe(8)-)		Recent Studies (post-2010) (angiotensin ii, des-phe(8)-)
137071,53321995

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clark, MA; Diz, DI; Tallant, EA1
Carretero, OA; Garvin, JL; Ren, Y1
Naito, Y; Takada, A; Takada, Y; Urano, T; Yoshida, M1

Other Studies

3 other study(ies) available for l 158809 and angiotensin ii, des-phe(8)-

ArticleYear
Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:4

    Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding, Competitive; Cells, Cultured; Down-Regulation; Imidazoles; Male; Muscle, Smooth, Vascular; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Regression Analysis; Tetrazoles; Type C Phospholipases

2001
Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles.
    Hypertension (Dallas, Tex. : 1979), 2002, Mar-01, Volume: 39, Issue:3

    Topics: Afferent Pathways; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterioles; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Kidney Glomerulus; Male; Norepinephrine; Peptide Fragments; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2002
L-158,809 and (D-Ala(7))-angiotensin I/II (1-7) decrease PAI-1 release from human umbilical vein endothelial cells.
    Thrombosis research, 2002, Mar-15, Volume: 105, Issue:6

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Dose-Response Relationship, Drug; Endothelium, Vascular; Fibrinolytic Agents; Humans; Imidazoles; Peptide Fragments; Plasminogen Activator Inhibitor 1; Tetrazoles; Tissue Plasminogen Activator; Umbilical Veins

2002